Clinical and Biological Markers in Hypereosinophilic Syndromes.

about

Clinical and Biological Markers in Hypereosinophilic Syndromes.

Item

http://www.wikidata.org/entity/Q49248245

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@en

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@nl

type

Item

label

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@en

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@nl

prefLabel

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@en

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@nl

P1476

Clinical and Biological Markers in Hypereosinophilic Syndromes.

@en

P2093

Amy D Klion

http://www.w3.org/2001/XMLSchema#string

Michelle Makiya

http://www.w3.org/2001/XMLSchema#string

Paneez Khoury

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases

Eosinophil granule proteins in peripheral blood granulocytes

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment

Episodic angioedema associated with eosinophilia

Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes

The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity.

Systemic activation of basophils and eosinophils: markers and consequences.

Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins.

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.

P304

240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMED.2017.00240

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312946

http://www.w3.org/2001/XMLSchema#string

P932

5743906

http://www.w3.org/2001/XMLSchema#string